Corsens Medical Overview
Corsens Medical has developed a lightweight, simple-to-operate, early-warning cardiac alert monitor for home use. Corsens received Pre-Marketing Notification (510(k)- K160656) clearance with the US FDA for its CPM. After the successful completion of initial human clinical trials proving safety and effectiveness, the company is in the process of extending its clinical data in cooperation with hospitals in Israel and preparing its FDA-cleared device for commercialization.
Cumulative Funding Raised Over Time ($)
Latest News
growth-positive
Corsens Medical's Cardiac Monitor Granted US FDA Clearance for 510(k) Pre-Marketing Notification.
Corsens Medical Ltd has received clearance for a Pre-Marketing Notification (510(k)) with the US Food and Drug Administration for its Corsens Cardiac Monitor. The monitor is designed to detect cardiac contractility parameters and provide continuous monitoring of heart activity. Corsens Medical is a development stage medical device company based in Tel Aviv, Israel.
Investment
Corsens Medical Ltd., Announces Filing of a 510(k) Pre-Marketing Notification with the US Food and Drug Administration for the Corsens Cardiac Monitor
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Seed |
| Rounds | 1 |
| Investors | 1 |
Team Members
2
Employees: 1-10
Web & Social Links
| Website | corsensmed.com |
Locations
Azrieli Center, Derech Menachem Begin, Tel Aviv-Yafo, Israel
Photos & Videos
No files yet
